BPC 157 Dosing (Common Protocols), Oral Subcutaneous, 500 mcg daily, Duration: 6 weeks, Intramuscular Peritendinous, 1 mg daily, Duration: 6 weeks, Note:, Not approved by FDA or BPC 157 Dosing (Common Protocols) Oral Subcutaneous 500 mcg daily Duration: 6 weeks Intramuscular Peritendinous 1 mg daily Duration: 6 weeks Note: Not approved Pentadecapeptide BPC 157 and the central nervous system_Chemicalbook BPC 157 Benefits and Research Applications Subcutaneous Injection Sites and Instructions for Safe Self Administration BPC 157: Science Backed Uses, Benefits, Dosage, and Safety